BCS & IVIVC Based Bio waivers

It is a substructure for compartment, drug material based on its solubility and absorptive It is a drug development device to explain ‘bio waiver’ in concurrence with the dissolution of the drug product. (BCS) based bio waivers the term bio waiver is request to a regulatory drug approval process when the dossier is accept based on conformation of equivalence other than in vivo bioequivalence test

 

  • BCS bio waivers
  • Preclinical and clinical testing for oral drug delivery
  • In vitro preclinical ADME/BCS testing
  • In vitro drug product research

Related Conference of BCS & IVIVC Based Bio waivers

July 27-28, 2026

19th World Drug Delivery Summit

Paris, France
July 27-28, 2026

39th World Congress on Pharmacology

Rome, Italy
September 14-15, 2026

6th International Conference on Pharmaceutical Chemistry

Paris, France
September 24-25, 2026

6th World Congress on Rare Diseases & Orphan Drugs

Paris, France
November 26-27, 2026

5th World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland
November 26-27, 2026

5th World Congress on Precision and Personalized Medicine

Zurich, Switzerland

BCS & IVIVC Based Bio waivers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in